Patricia Pavlinac, MS, PhD

Assistant Professor, Global Health

Adjunct Assistant Professor, Epidemiology

Dr. Patricia Pavlinac, MS, PhD, is an epidemiologist and Assistant Professor in the Department of Global Health at the University of Washington. Dr. Pavlinac also co-directs the Gut Health and Child Survival scientific priority area of the Global Center for Integrated Health of Women, Adolescents and Children (Global WACh). Her research aims to identify interventions to halt morbidity and mortality attributed to enteric infectious diseases in children. Dr. Pavlinac has extensive experience coordinating pediatric studies in Kenya including her current role as Project Director of two clinical trials testing whether empiric use of a broad-spectrum antibiotic improves post-acute survival and growth in Kenyan children. These trials build on evidence that Kenyan children suffer an elevated risk of mortality and chronic malnutrition after acute infectious illnesses that may be due to inadequately treated or new exposure to bacterial pathogens. Nested in these trials, her team is also evaluating the impact of azithromycin on antimicrobial resistance to provide policy-makers with a balanced perspective on the costs and benefits of empiric azithromycin use. 

1. Oreso, C, Ogwel, B, Awuor, AO, Anyango, RO, Kotloff, K, Hossain, MJ et al.. Frequency and correlates of non-receipt of age-appropriate vaccination among children aged 6-35 months with medically attended diarrhea: Findings from the Enterics for Global Health (EFGH) Shigella study, 2022-2024. PLOS Glob Public Health. 2026;6 (7):e0005670. doi: 10.1371/journal.pgph.0005670. PubMed PMID:42384629 PubMed Central PMC13322521.
2. Mategula, D, Conteh, B, McGrath, CJ, Feutz, E, Kotloff, KL, Awuor, AO et al.. The consequences of Shigella medically-attended diarrhoea and other leading pathogens among young children living in high-burden settings: a multi-country prospective cohort study. EClinicalMedicine. 2026;97 :104025. doi: 10.1016/j.eclinm.2026.104025. PubMed PMID:42382133 PubMed Central PMC13316610.
3. Kariuki, K, Tickell, KD, Kigen, C, Wachira, J, Mogeni, P, Rwigi, D et al.. Fluoroquinolone-resistant Escherichia coli carrying quinolone efflux pump (qepA) with L348-G349 duplication in the absence of V134I substitution. Microbiol Spectr. 2026; :e0005626. doi: 10.1128/spectrum.00056-26. PubMed PMID:42370683 .
4. Rao, SI, Tippett Barr, BA, Feutz, E, Vannice, K, Pavlinac, PB. Scientific writing capacity building with early career researchers during study implementation: The Enterics for Global Health seven-country experience. PLOS Glob Public Health. 2026;6 (6):e0006589. doi: 10.1371/journal.pgph.0006589. PubMed PMID:42284344 PubMed Central PMC13262805.
5. Mogeni, P, Ochieng, JB, Kariuki, K, Rwigi, D, Atlas, HE, Tickell, KD et al.. Impact of Azithromycin Administration at Hospital Discharge on Antimicrobial Resistance and Enteropathogen Carriage 3 Months Following Treatment. medRxiv. 2026; :. doi: 10.64898/2026.04.17.26351054. PubMed PMID:42078412 PubMed Central PMC13131741.